Verrica Pharmaceuticals (VRCA) Current Leases (2019 - 2026)
Verrica Pharmaceuticals (VRCA) posted quarterly Current Leases of $348000.0 for Q1 2026, up 8.41% year-over-year from $321000.0 in Q1 2025, and down 14.07% quarter-over-quarter from $405000.0 in Q4 2025.
Verrica Pharmaceuticals (VRCA) Current Leases (2019 - 2026) Analysis & Trends
Verrica Pharmaceuticals' Current Leases history runs 8 years deep, the most recent figure standing at $348000.0 for Q1 2026.
- In Q1 2026, Current Leases rose 8.41% year-over-year to $348000.0; the TTM figure through Mar 2026 stood at $348000.0 (up 8.41% YoY), while the FY2025 annual figure was $405000.0, up 28.57% from the prior year.
- Current Leases for Q1 2026 stood at $348000.0, down from $405000.0 in the prior quarter.
- The five-year high for Current Leases was $846000.0 in Q3 2024, with the low at $6000.0 in Q1 2022.
- The 5-year median for Current Leases is $321000.0 (2025), against an average of $372866.7.
- The sharpest annual moves came in 2022 and 2023: Current Leases tumbled 97.39% in 2022, then jumped 4933.33% in 2023.
- Verrica Pharmaceuticals' Current Leases stood at $283000.0 in 2022, then soared by 32.86% to $376000.0 in 2023, then declined by 16.22% to $315000.0 in 2024, then gained by 28.57% to $405000.0 in 2025, then dropped by 14.07% to $348000.0 in 2026.
- Business Quant data shows VRCA's Current Leases at $348000.0 in Q1 2026, $405000.0 in Q4 2025, and $335000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Verrica Pharmaceuticals | 102.80 Mn | 91.60 Mn | - | 601,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 601,000.00 |
| Mar 31, 2026 | 348,000.00 |
| Dec 31, 2025 | 405,000.00 |
| Sep 30, 2025 | 335,000.00 |
| Jun 30, 2025 | 318,000.00 |
| Mar 31, 2025 | 321,000.00 |
| Dec 31, 2024 | 315,000.00 |
| Sep 30, 2024 | 846,000.00 |
| Jun 30, 2024 | 719,000.00 |
| Mar 31, 2024 | 679,000.00 |
| Dec 31, 2023 | 376,000.00 |
| Sep 30, 2023 | 31,000.00 |
| Jun 30, 2023 | 309,000.00 |
| Mar 31, 2023 | 302,000.00 |
| Jun 30, 2022 | 283,000.00 |
| Mar 31, 2022 | 6,000.00 |
| Dec 31, 2021 | 6,000.00 |
| Sep 30, 2021 | 239,000.00 |
| Jun 30, 2021 | 7,000.00 |
| Mar 31, 2021 | 230,000.00 |